ARCHIVES

NCI Advisors Approve $160-Million Network For Biomarker Discovery, Validation

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | March 13, 2009

Download PDF Visit The Full Archive

Related Articles

SAIC Frederick Offers Use Of Drug Facility

August 4, 1995

FDA Approives Lilly’s Alimta For 1st-Line Metastatic NSCLC

September 26, 2008

Public Health Service: NIEHS, CDC to Study Population Exposure to Environmental Estrogens

December 12, 1997

Letter to the Editors: Loss Of ET2 Would Be Disheartening, Member Of Study Section Says

February 20, 1998

Clinical Trials Approved By NCI CTEP During May

June 28, 2002

In brief: Cancer Investment “Drop In The Bucket,” OMB Is The “Second Greatest Kill,” Pepper Says

August 10, 1979